Enlarge image
Students in the USA are campaigning for a law that would allow the administration of puberty blockers
Photo: Kathleen Batten / AP
The Health Service in England has stopped prescribing puberty blockers to children.
The British news agency PA reported this on Tuesday, citing NHS England.
The drugs that prevent the onset of puberty symptoms such as menstruation, breast growth and voice loss will therefore only be allowed to be used in clinical studies in the future.
An independent investigation into the health service's gender identity services had previously criticized that there was insufficient data and knowledge about the long-term effects of the medication.
The number of children referred to the relevant service has risen sharply in recent years.
However, studies so far show that the effects of the medication are reversible.
They also help reduce depression and suicide rates among transgender youth.
The Conservative government in London welcomed the decision.
"We have always made it clear that the safety and well-being of children is our top priority, which is why we welcome this landmark decision," said Health Secretary Maria Caulfield.
Ending the routine prescription of puberty blockers will help ensure care is based on science and expert opinion and in the best interests of the child.
According to PA, fewer than 100 young people in England are currently taking puberty blockers.
They should therefore be allowed to continue their treatment.
However, the topic is sometimes extremely controversial.
Former Conservative Prime Minister Liz Truss is currently campaigning for a complete ban on puberty blockers.
lpz/dpa